DOI: https://doi.org/10.36347/sjams.2025.v13i06.016

Pages: 1331-1335

Background: Esophageal carcinoma is a malignancy with high morbidity and mortality, often diagnosed at an advanced stage due to the absence of early symptoms. Computed tomography (CT) plays a crucial role in evaluating tumor extent, lymph node involvement, and distant metastasis, aiding in treatment planning. Objective: This study aims to assess the computed tomographic findings in patients with esophageal carcinoma in a tertiary care hospital in Bangladesh. Methods: This descriptive observational study was conducted at Test Hospital, Dhaka, Bangladesh, from January 2023 to December 2024. A total of 47 patients diagnosed with esophageal carcinoma were included using purposive sampling. CT imaging was performed to evaluate tumor location, size, wall thickening, luminal narrowing, invasion into adjacent structures, lymph node involvement, and distant metastasis. Data analysis was conducted using MS Office tools. Results: Of the 47 patients, 63.8% were male, with a mean age of 59.2 years. Tumor localization was most common in the middle esophagus (46.8%), followed by the lower esophagus (38.3%). Lymph node involvement was observed in 72.3%, and distant metastases were present in 38.3%. The majority of patients were diagnosed at stage III (48.9%) and stage IV (38.3%). Conclusion: Computed tomography provides valuable insights into the staging and progression of esophageal carcinoma. The high prevalence of late-stage diagnosis emphasizes the need for early detection. Enhanced imaging and screening strategies, along with targeted interventions, are essential to improve patient outcomes and survival rates.